Research/Scholarly Activities

Division Statement | Faculty | Research/Scholarly Activities | Fellowship | Quillen ETSU Physicians

Scholarship in the Division of Hematology/Oncology

The Division of Hematology/Oncology at East Tennessee State University is an academic hematology-oncology program committed to the delivery of quality cancer care to the people of this region and to the delivery of quality teaching to our medical students, internal medicine residents and medical oncology fellows at the James H. Quillen College of Medicine. We achieve our ideals through integrated programs in cancer therapy, cancer prevention, basic and translational research and clinical trials. Faculty members collaborate with scientists throughout the university and participate in both basic and clinical research and scholarship, most notably with a focus on:

Recent Publications by the Division include:

McGoldrick CA, Jiang YL, Paromov V, Brannon M, Krishnan K, Stone WL. Identification of oxidized protein hydrolase as a potential prodrug target in prostate cancer. MC Cancer. 2014 Feb 10;14(1):77. [Epub ahead of print] PMID: 24512522

Shi Lei, Jia M. Wang, Jun P. Ren, Yong Q. Cheng, Ruo S. Ying, Xiao Y. Wu, Shu M. Lin, Jeddidiah Stone WL, Krishnan K, Campbell SE, Palau VE. The role of antioxidants and pro-oxidants in colon cancer. World J.Gastrointest.Oncol. 2014 Mar 15;6(3):55-66.

Chakraborty K, Ramsauer VP, Stone WL, Krishnan K. Tocotrienols in the treatment and prevention of pancreatic cancer. Oxidative Stress and Dietary Antioxidants, Editors, Victor Preedy; Elsevier, Academic Press, 2014

Sharon E. Campbell, Aashish S. Morani, William L. Stone, Koyamangalath Krishnan and Victoria E. Palau, Vitamin E Isoforms: Multiple Mechanisms of Action against Carcinogenesis, In: Free Radicals: The role of Antioxidants and Prooxidants in Cancer Development. Editors: William Stone, NOVA publishers 2014

William L. Stone, Yu Lin Jiang, Christopher McGoldrick, Marianne Brannon and Koymangalath Krishnan The Design, Synthesis and In Vitro Evaluation of a Novel Pro-Oxidant Anticancer Prodrug Substrate Targeted to Acylamino-Acid-Releasing Enzyme. In: Free Radicals: The role of Antioxidants and Prooxidants in Cancer Development. Editors: William Stone, NOVA publishers 2014